PVG.L Regulatory News (PVG)

23 Feb 2007 09:00

Ark Therapeutics Group PLC23 February 2007 Ark Therapeutics Group plc 2007 Notification of Major Interests in Shares TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): ARK THERAPEUTICS GROUP PLC 2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights: ( ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( x ) Other ( ) ................. 3. Full name of person(s) subject to the notification obligation (iii): Fidelity International Limited (FIL) 4. Full name of shareholder(s) (if different from 3.) (iv): See schedule below 5. Date of the transaction and date on which the threshold is crossed or reachedif different) (v): Revised due to DTR rules 6. Date on which issuer notified: 22 February 2007 7. Threshold(s) that is/are crossed or reached: Not disclosed 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction (vi) Number of shares Number of voting Rights (viii) ISINGB0034251727 10,179,628 10,179,628 Resulting situation after the triggering transaction (vii) Class/type of shares Number of shares Number of voting rights % of voting rights if possible using (ix) the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect ISINGB0034251727 10,179,628 6.13% B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Date Exercise/Conversion Number of voting % of voting financial (xiii) Period/ Date (xiv) rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 10,179,628 6.13% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): See schedule below Proxy Voting: 10. Name of the proxy holder: Fidelity International Limited 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: As discussed with the FSA, prior to the implementation of the EU Transparency Directive, Fidelity aggregated the interests in shares of FMR Corp (FMR) andFidelity International Limited (FIL) together for the purposes of shareholder reporting. According to the new DTR rules, Fidelity are now reporting the indirect holdings of FMR and FIL separately. For this issuer FMR has no holdings. Please note that these holdings are correct as at close of business20 February 2007. 14. Contact name: Teresa Garry 15. Contact telephone number: 01737 837092 16. Contact name and telephone at issuer: NICK PLUMMER Company Secretary Ark Therapeutics Group plc 020 7388 7722 Schedule Security: ARK THERAPEUTICS GROUP PLC Current ownership percentage 6.13% Total Shares Held 10,179,628 Shares in Issue: 165,933,858 Shares Held Management Nominee/Registered Name Company 1,615,493 FIL STATE STR BK AND TR CO LNDN (S 44,035 FISL JP MORGAN, BOURNEMOUTH 365,500 FIJ BROWN BROTHERS HARRIMAN AND CO7,975,300 FIL BROWN BROS HARRIMN LTD LUX 179,300 FPM BANK OF NEW YORK BRUSSELS 22 February 2007 END This information is provided by RNS The company news service from the London Stock Exchange